نتائج البحث 511-520 من 11736 لعملية البحث عن Assay
... assayed from blood of cases with CAP and controls without history of cancer. Epidemiology of Chronic Lymphocytic Leukemia. Rochester, Minn. The overall goals ...
... assays using patient peripheral blood immune cells or serum. 3D Ultrasound For The Imaging Of Axillary Lymph Nodes In Patients With Breast Cancer. Rochester ...
Eligible participants with mCRC will be enrolled into specific treatment arms based on their biomarker assay results. Reduced Dose Hypofractionated ...
Rochester, Minn. The purpose of this study is to compare whether minimal residual disease (MRD) flow cytometric assay is not affected by different ...
The purpose of ORACLE is to demonstrate the ability of a novel ctDNA assay developed by Guardant Health to detect recurrence in individuals treated for early- ...
Eligible participants with mCRC will be enrolled into specific treatment arms based on their biomarker assay results. التصفّح دراسات سريرية. السابقالصفحة ...
Eligible participants with mCRC will be enrolled into specific treatment arms based on their biomarker assay results. A Phase I/II, open-label, multi-center ...
cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease (CAMPERR). Rochester, Minn. The purpose of this ...
لا تُقدم Mayo Clinic الدعم للشركات أو المنتجات المُعلَّن عنها هنا. لكن تدعم العائدات الإعلانية رسالتنا غير الربحية.
تحقق من هذه الكتب الأكثر مبيعًا والعروض الخاصة على الكتب والنشرات الإخبارية من Mayo Clinic Press.
تساهم التبرّعات، وهي قابلة للخصم الضريبي، في دعم آخر التطورات في الأبحاث وطرق الرعاية لإحداث نقلة نوعية في الطب.